|

Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle

RECRUITINGSponsored by Corporacion Parc Tauli
Actively Recruiting
SponsorCorporacion Parc Tauli
Started2025-01-07
Est. completion2027-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07298720

Summary

Proof-of-concept observational study including ICU patients undergoing a PLR maneuver. Local microvasculature will be assessed with the hDOS platform on the brachioradialis muscle, deriving the microvascular blood flow index (BFI) and tissue oxygen saturation (StO2). CO will be assessed via an invasive hemodynamic monitor based on pulse waveform analysis through the patient's arterial line. The correlation over time between CO and microvascular parameters, and the ability of microvascular variables for predicting a positive CO response (increase \> 10%) will be assessed.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Invasive blood pressure monitoring through an arterial line

Exclusion Criteria:

* Patients with suspected pregnancy
* Intra-abdominal hypertension
* Elevated intracranial pressure

Conditions2

Critical IllnessHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.